TELA Bio (TELA) Free Cash Flow (2018 - 2026)

TELA Bio has reported Free Cash Flow for 9 years, with the latest figure at -$9.4 million in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 17.72% year-over-year to -$9.4 million in Q2 2026; TTM through Jun 2026 was -$31.6 million, a 8.81% increase from a year earlier, with the FY2025 full-year figure at -$28.7 million, up 32.68% from the prior year.
• Free Cash Flow was -$9.4 million for Q2 2026 at TELA Bio, up from -$11.3 million in the prior quarter.
• The five-year high for Free Cash Flow was -$5.0 million in Q4 2025, with the low at -$14.7 million in Q1 2024.
• Average Free Cash Flow over 5 years is -$9.7 million, with a median of -$10.3 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 109.93% in 2022, then jumped 36.36% in 2025.
• Over 5 years, Free Cash Flow stood at -$11.0 million in 2022, then dropped by 2.06% to -$11.3 million in 2023, then surged by 30.75% to -$7.8 million in 2024, then surged by 36.36% to -$5.0 million in 2025, then plunged by 90.28% to -$9.4 million in 2026.
• The last three Free Cash Flow figures came in at -$9.4 million (Q2 2026), -$11.3 million (Q1 2026), and -$5.0 million (Q4 2025), per Business Quant data.